Ładuje się......
COVID-19 and immune checkpoint inhibitors: initial considerations
COVID-19 infections are characterized by inflammation of the lungs and other organs that ranges from mild and asymptomatic to fulminant and fatal. Patients who are immunocompromised and those with cardiopulmonary comorbidities appear to be particularly afflicted by this illness. During pandemic cond...
Zapisane w:
| Wydane w: | J Immunother Cancer |
|---|---|
| Główni autorzy: | , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BMJ Publishing Group
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7246104/ https://ncbi.nlm.nih.gov/pubmed/32434790 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000933 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|